id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-266896-unb9yvjr	Nihei, Yoshihito	Continuous extracorporeal treatments in a dialysis patient with COVID-19	2020-10-04		.txt	text/plain	2821	127	44	Inflammatory cytokine storm caused by SARS-CoV-2 infection has been reported to play a central role in COVID-19; therefore, treatments for suppressing cytokines, including extracorporeal treatments, are considered to be beneficial. The cytokine storm caused by SARS-CoV-2 infection, primarily characterised by elevated plasma concentrations of interleukin 6 (IL-6), plays a central role in COVID-19 [2] ; therefore, its suppression is considered a key treatment approach in patients with COVID-19. Especially, CHDF is reported to continually suppress inflammatory cytokines and has been used in critically ill patients, including those with septic shock, ARDS and infections with viruses such as severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus [5] . We herein present a patient on PD who became critically ill due to COVID-19 and was treated with several extracorporeal treatments including PE, PMX-DHP and CHDF to suppress the cytokine storm.	./cache/cord-266896-unb9yvjr.txt	./txt/cord-266896-unb9yvjr.txt